MedTrace Logo

Role of EUS in Detection of Liver Metastasis

NCT04509492 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2021-05-18

No results posted yet for this study

Summary

Liver metastasis may not be detected by CT and MRI due to their small size while they can be detected by EUS. Also, EUS-FNA has a great impact in improving the diagnostic accuracy of EUS. Objectives: To assess the feasibility of EUS in the detection of occult small hepatic focal lesions at the time of primary tumor staging, not seen by CT or MRI.

Conditions

  • Liver Metastases
  • Pancreatic Neoplasms

Interventions

DIAGNOSTIC_TEST

Endoscopic ultrasound ( EUS )

\- EUS will be done to all patients. During EUS examination the liver will be examined thoroughly to detect hepatic focal lesions with possible EUS-FNA of any detected lesions. All EUS examination will being done by EUS linear array Echoendoscope, Pentax EG-3870UTK attached to Hitachi Avius US machine under Propofol deep sedation

Sponsors & Collaborators

  • Mahmoud Wahba

    lead OTHER

Principal Investigators

  • hussein Okasha, MD · Cairo University

Eligibility

Min Age
12 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-04-21
Completion
2021-04-21

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04509492 on ClinicalTrials.gov